RDA Financial Network

Position in GILD — Gilead Sciences, Inc.

CIK 1774086 AKRON, IA

Position in GILD

as of Jun 30, 2026 · filed Jul 6, 2026 Compact

Position Value

$234,613

-$55,276 QoQ

Shares Held

1,857

-10.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#1,822

of 2,266 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

RDA Financial Network holds $10,624,897 across 8 Drug Manufacturers - General names. GILD ranks #7 (2.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	4,517	$5,417,825
2	PFE	Pfizer Inc	69,539	$1,674,499
3	JNJ	Johnson & Johnson	5,338	$1,355,691
4	ABBV	AbbVie Inc.	3,122	$785,620
5	BIIB	Biogen Inc.	3,000	$648,180
6	AMGN	Amgen Inc	836	$302,732
7	GILD	Gilead Sciences, Inc. This page	1,857	$234,613
8	AZN	Astrazeneca PLC	1,085	$205,737

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$234,613	1,857	-10.7%	Shares	Sole	2026-07-06
2026-03-31	$289,889	2,080	-0.3%	Shares	Sole	2026-04-08
2025-12-31	$256,158	2,087	-3.1%	Shares	Sole	2026-01-06
2025-09-30	$238,983	2,153	+1.1%	Shares	Sole	2025-10-08
2025-06-30	$236,042	2,129	+5.1%	Shares	Sole	2025-07-07
2025-03-31	$227,013	2,026	-61.0%	Shares	Sole	2025-04-14
2023-06-30	$399,916	5,189	+17.2%	Shares	Sole	2023-07-13
2023-03-31	$367,391	4,428	+14.2%	Shares	Sole	2023-04-12
2022-12-31	$332,926	3,878	+16.4%	Shares	Sole	2023-01-10
2020-09-30	$210,549	3,332	+1.4%	Shares	Sole	2020-10-13
2020-06-30	$252,901	3,287	-20.6%	Shares	Sole	2020-07-14
2020-03-31	$309,581	4,141	—	Shares	Sole	2020-04-06
No filing history on record for this holder in this stock.